Purine metabolites regulate leukemic cell sensitivity toward cytarabine

Purine metabolites regulate leukemic cell sensitivity toward cytarabine

Not available.

Saved in:

Bibliographic Details
Main Authors:	Xiaowen Zhang, Ang Jia, Jianwei You, Zixuan Zhuang, Yinfei Wang, Ting Liu, Xingrong Du, Linzhang Huang, Peng Li, Tong-Jin Zhao, Craig T. Jordan, Li Chen, Ji-Hao Zhou, Haobin Ye
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-01-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/11896
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Case report: Dysphonia associated with high-dose cytarabine therapy
by: Ling Ma, et al.
Published: (2025-01-01)

Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia
by: Brandi Anders, et al.
Published: (2017-01-01)

Purin-6-One Derivatives as Phosphodiesterase-2 Inhibitors
by: Wei Yuan, et al.
Published: (2016-01-01)

Blimp-1 orchestrates macrophage polarization and metabolic homeostasis via purine biosynthesis in sepsis
by: Wenjuan Peng, et al.
Published: (2025-02-01)

Analysis of parameters of purine metabolism in patients with diabetes mellitus type 2
by: A.O. Chernyaeva, et al.
Published: (2023-12-01)

Changes of Cell Adhesion Molecules and T Cell Subset Populations in Acute Myeloid Leukemia Patients Undergoing Intravenous Administration of Cytarabine Supplemented with Idarubicin
by: Jinhua Piao, et al.
Published: (2022-01-01)

The Bone Marrow Microenvironment as Niche Retreats for Hematopoietic and Leukemic Stem Cells
by: Felix Nwajei, et al.
Published: (2013-01-01)

The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction
by: Giulia Cheloni, et al.
Published: (2017-01-01)

Redox-dependent purine degradation triggers postnatal loss of cardiac regeneration potential
by: Yuichi Saito, et al.
Published: (2025-02-01)

The use of urinary purine derivatives to estimate microbial protein supply and feed intake
by: Şule Kaya

Undetected Severe Fetal Myelosuppression following Administration of High-Dose Cytarabine for Acute Myeloid Leukemia: Is More Frequent Surveillance Necessary?
by: Jessica Parrott, et al.
Published: (2017-01-01)

ASSOCIATION BETWEEN LEUKEMIC EVOLUTION AND UNCOMMON CHROMOSOMAL ALTERATIONS IN PEDIATRIC MYELODYSPLASTIC SYNDROME
by: Viviane Lamim Lovatel, et al.
Published: (2024-01-01)

Resensitizing β‐Lactams by Reprogramming Purine Metabolism in Small Colony Variant for Osteomyelitis Treatment
by: Tingwang Shi, et al.
Published: (2025-02-01)

Recipient sex and donor leukemic cell characteristics determine leukemogenesis in patient-derived models
by: Anna MP. Stanger, et al.
Published: (2025-01-01)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
by: Eko A. Pangarsa, et al.
Published: (2021-01-01)

Purine-Metabolizing Ectoenzymes Control IL-8 Production in Human Colon HT-29 Cells
by: Fariborz Bahrami, et al.
Published: (2014-01-01)

Purine-Functionalized Ferrocene Derivatives: Efficient Redox Catalysts for Oxidation of Methyl Blue and Reduction of Trinitrophenol
by: Sagar R. Sangani, et al.
Published: (2024-11-01)

Synthesis, Characterization, and Thermal and Antimicrobial Activities of Some Novel Organotin(IV): Purine Base Complexes
by: Reena Jain, et al.
Published: (2013-01-01)

Desarrollo participativo de purín de bardana en una colonia en transición agroecológica
by: César Di CIOCCO, et al.
Published: (2022-12-01)

Combinatorial co-expression of xanthine dehydrogenase and chaperone XdhC from Acinetobacter baumannii and Rhodobacter capsulatus and their applications in decreasing purine content in food
by: Chenghua Wang, et al.
Published: (2023-07-01)

Effects of annexin A1 on apoptosis and cell cycle arrest in human leukemic cell lines
by: Sabran Affidah, et al.
Published: (2019-03-01)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
by: Lucas Touzet, et al.
Published: (2019-03-01)

Assessment of the Diagnostic and Prognostic Values of CD200 and CD43 in CLL and Leukemic Phase of NHL
by: Teeb M. Jaafar Al-Khafaji, et al.
Published: (2024-12-01)

Hematopoietic stem cell transplantation for purine nucleoside phosphorylase deficiency with two novel mutations: a case report and review of literature
by: Minyuan Liu, et al.
Published: (2025-12-01)

Exploring chitin metabolite profiles and sensitivity differences in Collembola species exposed to teflubenzuron
by: Saúl Fernandes, et al.
Published: (2025-01-01)

Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
by: Jongbok Lee, et al.
Published: (2025-01-01)

How does gut microbiota affect the vaginitis axis? The mediating role of plasma metabolites
by: Mo Li, et al.
Published: (2025-02-01)

Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness
by: Linu A. Jacob, et al.
Published: (2015-01-01)

Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study
by: Asaad Trabolsi, et al.
Published: (2025-02-01)

Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells
by: Kohei Mitsuno, et al.
Published: (2025-02-01)

Purine-rich element binding protein alpha: a DNA/RNA binding protein with multiple roles in cancers
by: Shiyi Yu, et al.
Published: (2025-01-01)

Screening and identification of purine degrading Lactobacillus fermentum 9-4 from Chinese fermented rice-flour noodles
by: Lianghua Lu, et al.
Published: (2022-09-01)

Exploring purine analogues as inhibitors against Katanin, a microtubule severing enzyme using molecular modeling approach
by: Vibhuti Saxena, et al.
Published: (2024-12-01)

Utilizing integrated bioinformatics and machine learning approaches to elucidate biomarkers linking sepsis to purine metabolism-associated genes
by: Fanqi Liang, et al.
Published: (2025-01-01)

Aggressive CD5-Positive Primary Bone Marrow Diffuse Large B-Cell Lymphoma with Leukemic Presentation
by: Mark G. Evans, et al.
Published: (2021-01-01)

Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia
by: Qi Zhou, et al.
Published: (2025-02-01)

CD4+ T Cells Mediate Dendritic Cell Licensing to Promote Multi‐Antigen Anti‐Leukemic Immune Response
by: Luis Gil‐de‐Gómez, et al.
Published: (2025-01-01)

In Vitro models of leukemia development: the role of very small leukemic stem-like cells in the cellular transformation cascade
by: Jan Jakub Lica, et al.
Published: (2025-01-01)

Acute Leukemia Induces Senescence and Impaired Osteogenic Differentiation in Mesenchymal Stem Cells Endowing Leukemic Cells with Functional Advantages
by: Ximena Bonilla, et al.
Published: (2019-01-01)

Correlation between P-glycoprotein and CD34 Expressions in Leukemic Cells from De novo Acute Myeloid Leukemia
by: Yulia Nadar Indrasari, et al.
Published: (2024-12-01)